NDC 66993-489-83 - Dactinomycin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66993-489
- Requested NDC
- 66993-489-83
- Package NDCs from labels
- 66993-489-83, 66993-489-35
- Manufacturer
- Prasco Laboratories | Baxter Oncology GmbH
- Effective date
- 2024-01-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dactinomycin - Prasco Laboratories | Baxter Oncology GmbH | Prasco Laboratories | Baxter Oncology GmbH | 2024-01-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66993-489-83 | EA - Each | 66993-489 | 7ced7679-c45a-4125-99fd-aaee04d45327 | 1 | 2018-01-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| DACTINOMYCIN | DACTINOMYCIN | Eugia US LLC | 5da55538-2602-4704-a9da-603c9f7ff7dc | 2024-06-18 | Warnings, Adverse reactions | 1CC1JFE158 |
| dactinomycin | DACTINOMYCIN | XGen Pharmaceuticals DJB, Inc. | efe03d73-eb11-45ff-a3cb-09a540ed352f | 2024-05-28 | Warnings, Adverse reactions | 1CC1JFE158 |
| Dactinomycin | DACTINOMYCIN | Hisun Pharmaceuticals USA, Inc. | 95d5c152-aa00-41e6-83e8-8df374a56447 | 2024-05-08 | Warnings, Adverse reactions | 1CC1JFE158 |
| MANNITOL | MANNITOL | HF Acquisition Co LLC, DBA HealthFirst | 999ce711-2d5b-0d7d-e053-2995a90a2689 | 2024-01-27 | Warnings, Adverse reactions | 3OWL53L36A |
| 174017f5-073b-4eb1-8be6-a9de2d328695 | 5e1a64c2-283a-51a7-e053-2991aa0af15f | 2024-01-18 | Warnings, Adverse reactions | 174017f5-073b-4eb1-8be6-a9de2d328695 5e1a64c2-283a-51a7-e053-2991aa0af15f | ||
| DACTINOMYCIN | DACTINOMYCIN | Eugia US LLC | aa047ee8-f2e8-4720-84b1-d1c4532d6c63 | 2023-12-20 | Warnings, Adverse reactions | 1CC1JFE158 |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| Dactinomycin | DACTINOMYCIN | Meitheal Pharmaceuticals Inc. | 2aaca42a-3b79-4151-a727-83253556a540 | 2020-11-13 | Warnings, Adverse reactions | 1CC1JFE158 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.